Showing results (121-130 of 217) with videos related to

Sort By:
Pageof 22
Cancers|November 13, 2021
Impact of Serum γ-Glutamyltransferase on Overall Survival in Men with Metastatic Castration-Resistant Prostate Cancer Treated with DocetaxelMinami Une, Kosuke Takemura, Kentaro Inamura, et al.
IJU Case Reports|September 9, 2021
The utility of diffusion-weighted whole-body imaging with background body signal suppression in detecting metastatic lesion of germ cell carcinomaKasumi Kaneko Yoshitomi, Noboru Numao, Yosuke Umino, et al.
American Journal of Physiology. Heart and Circulatory Physiology|May 19, 2004
Remodeling of the chronic severely failing ischemic sheep heart after coronary microembolization: functional, energetic, structural, and cellular responsesYifei Huang, Stephen N Hunyor, Lele Jiang, et al.
International Journal of Cancer|March 10, 2011
Antitumor effect of sunitinib against skeletal metastatic renal cell carcinoma through inhibition of osteoclast functionShinya Maita, Takeshi Yuasa, Norihiko Tsuchiya, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|May 24, 2021
First-line combination chemotherapy with etoposide, ifosfamide and cisplatin for the treatment of disseminated germ cell cancer: Efficacy and feasibility in current clinical practiceMotohiro Fujiwara, Hajime Tanaka, Takeshi Yuasa, et al.
Cancer Letters|August 23, 2005
The third-generation bisphosphonates inhibit proliferation of murine osteosarcoma cells with induction of apoptosisNaoyuki Horie, Hiroaki Murata, Yasunori Nishigaki, et al.
International Journal of Cancer|March 10, 2005
Cytotoxic effects of gammadelta T cells expanded ex vivo by a third generation bisphosphonate for cancer immunotherapyKiyoshi Sato, Shinya Kimura, Hidekazu Segawa, et al.
Nutrition and Cancer|November 30, 2022
Geriatric Nutritional Risk Index as a Predictor of Prognosis in Metastatic Renal Cell Carcinoma Treated with NivolumabRyo Fujiwara, Takeshi Yuasa, Shinya Yamamoto, et al.
Cancer Diagnosis & Prognosis|May 11, 2023
Prognostic Significance of Immune-related Adverse Events in Metastatic Renal Cell Carcinoma Patients Treated With Immune-checkpoint-inhibitorsYosuke Yasuda, Ryo Fujiwara, Tomohiko Oguchi, et al.
Urology|February 15, 2011
Tumor size is a potential predictor of response to tyrosine kinase inhibitors in renal cell cancerTakeshi Yuasa, Shinji Urakami, Shinya Yamamoto, et al.
Pageof 22